1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
- 2011
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
- 2005
-
Mark
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
(
- Contribution to journal › Article
- 2002
-
Mark
Cell replacement therapy in human neurodegenerative disorders
(
- Contribution to journal › Article
-
Mark
Role of cell therapy in Parkinson disease.
(
- Contribution to journal › Article
- 2000
-
Mark
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
(
- Contribution to journal › Article
- 1999
-
Mark
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
(
- Contribution to journal › Article
- 1995
-
Mark
Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro
(
- Contribution to journal › Article
- 1994
-
Mark
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
(
- Contribution to journal › Article
- 1992
-
Mark
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(
- Contribution to journal › Article